Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer.
Imai H, Mori K, Wakuda K, Ono A, Akamatsu H, Shukuya T, Taira T, Kenmotsu H, Naito T, Kaira K, Murakami H, Endo M, Nakajima T, Yamamoto N, Takahashi T. Imai H, et al. Among authors: nakajima t. Ann Thorac Med. 2015 Jan-Mar;10(1):61-6. doi: 10.4103/1817-1737.146885. Ann Thorac Med. 2015. PMID: 25593610 Free PMC article.
Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy.
Imai H, Mori K, Ono A, Akamatsu H, Taira T, Kenmotsu H, Naito T, Kaira K, Murakami H, Endo M, Nakajima T, Takahashi T. Imai H, et al. Among authors: nakajima t. Med Oncol. 2014 Aug;31(8):88. doi: 10.1007/s12032-014-0088-3. Epub 2014 Jun 25. Med Oncol. 2014. PMID: 24961467 Clinical Trial.
Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer.
Hisamatsu Y, Murakami H, Akamatsu H, Kimura M, Mori K, Imai H, Ono A, Shukuya T, Taira T, Kenmotsu H, Naito T, Endo M, Nakajima T, Takahashi T, Yamamoto N. Hisamatsu Y, et al. Among authors: nakajima t. Thorac Cancer. 2014 Mar;5(2):121-5. doi: 10.1111/1759-7714.12071. Epub 2014 Mar 3. Thorac Cancer. 2014. PMID: 26766988 Free PMC article.
Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy.
Kasahara N, Imai H, Kaira K, Mori K, Wakuda K, Ono A, Taira T, Kenmotsu H, Harada H, Naito T, Murakami H, Endo M, Nakajima T, Yamada M, Takahashi T. Kasahara N, et al. Among authors: nakajima t. Radiol Oncol. 2015 Nov 27;49(4):409-15. doi: 10.1515/raon-2015-0037. eCollection 2015 Dec. Radiol Oncol. 2015. PMID: 26834529 Free PMC article.
Individual-level data on the relationships of progression-free survival, post-progression survival, and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancer.
Imai H, Takahashi T, Mori K, Ono A, Akamatsu H, Shukuya T, Taira T, Kenmotsu H, Naito T, Murakami H, Endo M, Nakajima T, Yamamoto N. Imai H, et al. Among authors: nakajima t. Neoplasma. 2014;61(2):233-40. doi: 10.4149/neo_2014_030. Neoplasma. 2014. PMID: 24299320
Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer.
Ono A, Naito T, Ito I, Watanabe R, Shukuya T, Kenmotsu H, Tsuya A, Nakamura Y, Murakami H, Kaira K, Takahashi T, Kameya T, Nakajima T, Endo M, Yamamoto N. Ono A, et al. Among authors: nakajima t. Lung Cancer. 2012 Jun;76(3):439-44. doi: 10.1016/j.lungcan.2011.12.012. Epub 2012 Jan 31. Lung Cancer. 2012. PMID: 22300752
6,020 results